PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 123 filers reported holding PULMONX CORP in Q3 2021. The put-call ratio across all filers is 0.15 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $7,502,658 | -10.1% | 726,298 | +14.1% | 1.42% | +28.4% |
Q2 2023 | $8,343,309 | +17.1% | 636,408 | -0.2% | 1.10% | +53.3% |
Q1 2023 | $7,127,395 | -16.8% | 637,513 | -37.3% | 0.72% | +63.1% |
Q4 2022 | $8,567,055 | -34.0% | 1,016,258 | +30.5% | 0.44% | -41.1% |
Q3 2022 | $12,978,000 | -33.6% | 778,978 | -41.3% | 0.75% | -33.8% |
Q2 2022 | $19,534,000 | +33.5% | 1,327,065 | +125.0% | 1.13% | +139.2% |
Q1 2022 | $14,631,000 | -5.0% | 589,722 | +22.8% | 0.47% | -15.1% |
Q4 2021 | $15,396,000 | -49.2% | 480,088 | -43.0% | 0.56% | -39.5% |
Q3 2021 | $30,287,000 | +15.3% | 841,764 | +41.4% | 0.92% | +12.9% |
Q2 2021 | $26,262,000 | +29.6% | 595,231 | +34.4% | 0.82% | +41.6% |
Q1 2021 | $20,258,000 | -25.2% | 442,896 | +12.8% | 0.58% | -41.4% |
Q4 2020 | $27,100,000 | – | 392,642 | – | 0.98% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ABG-WTT Global Life Science Capital Partners GP Ltd | 60,204 | $886,000 | 3.13% |
PURA VIDA INVESTMENTS, LLC | 1,327,065 | $19,534,000 | 1.13% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,465,901 | $51,018,000 | 1.05% |
NEXT CENTURY GROWTH INVESTORS LLC | 453,098 | $6,669,000 | 0.87% |
Novo Holdings A/S | 510,555 | $7,515,000 | 0.37% |
Rock Springs Capital Management LP | 702,400 | $10,339,000 | 0.30% |
RTW INVESTMENTS, LP | 691,255 | $10,175,000 | 0.26% |
TimesSquare Capital Management, LLC | 1,214,204 | $17,873,000 | 0.25% |
FORMULA GROWTH LTD | 54,951 | $809,000 | 0.22% |
Champlain Investment Partners, LLC | 2,129,760 | $31,350,000 | 0.20% |